Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex vivo efficacy of BCMA-bispecific antibody TNB-383B in relapsed/refractory multiple myeloma.
Foureau DM, Bhutani M, Robinson M, Guo F, Pham D, Buelow B, Steuerwald N, Rigby K, Tjaden E, Leonidas M, Paul BA, Atrash S, Ndiaye A, Symanowski JT, Voorhees PM, Usmani SZ. Foureau DM, et al. Among authors: bhutani m. EJHaem. 2020 Aug 1;1(1):113-121. doi: 10.1002/jha2.69. eCollection 2020 Jul. EJHaem. 2020. PMID: 35847733 Free PMC article.
Multiple myeloma: is it time for biomarker-driven therapy?
Bhutani M, Landgren O, Usmani SZ. Bhutani M, et al. Am Soc Clin Oncol Educ Book. 2015:e493-503. doi: 10.14694/EdBook_AM.2015.35.e493. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993214 Free article. Review.
Defining and treating high-risk multiple myeloma.
Usmani SZ, Rodriguez-Otero P, Bhutani M, Mateos MV, Miguel JS. Usmani SZ, et al. Among authors: bhutani m. Leukemia. 2015 Nov;29(11):2119-25. doi: 10.1038/leu.2015.209. Epub 2015 Aug 12. Leukemia. 2015. PMID: 26265183 Review.
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani SZ, Choyke PL, Kurdziel K, Landgren O. Bhutani M, et al. Leuk Lymphoma. 2016 May;57(5):1114-21. doi: 10.3109/10428194.2015.1090572. Epub 2016 Apr 7. Leuk Lymphoma. 2016. PMID: 26690712 Free PMC article.
Practical Considerations in Managing Relapsed Multiple Myeloma.
Agarwal A, Chow E, Bhutani M, Voorhees PM, Friend R, Usmani SZ. Agarwal A, et al. Among authors: bhutani m. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):69-77. doi: 10.1016/j.clml.2016.11.010. Epub 2016 Nov 23. Clin Lymphoma Myeloma Leuk. 2017. PMID: 27986429 Review.
Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials.
Bhutani M, Zhang Q, Friend R, Voorhees PM, Druhan LJ, Barlogie B, Sonneveld P, Morgan GJ, Symanowski JT, Avalos BR, Copelan EA, Usmani SZ. Bhutani M, et al. Lancet Haematol. 2017 Sep;4(9):e443-e451. doi: 10.1016/S2352-3026(17)30143-6. Lancet Haematol. 2017. PMID: 28863804
618 results